- This event has passed.
2nd Annual Thomas C. Shea Clinical Cancer Symposium
September 23 @ 7:30 am - 5:00 pm
The 2nd Annual Thomas C. Shea Clinical Cancer Symposium will highlight clinical and translational research focusing on upper respiratory malignancies (neck, head, and lung cancers). We will seek to educate on current clinical standard of care and the most promising new and emerging therapies likely to improve care over the next few years. Faculty, trainees, and healthcare professionals from UNC Health and medical schools in North Carolina, as well as community oncologists in North Carolina and throughout the Southeast are invited to attend.
The Umstead Hotel and Spa
100 Woodland Pond Drive
Cary, North Carolina 27513
United States
Map It
Registration for this year’s event is FREE. While registration is free, we do have a strict no-show policy. If you register and do not cancel by Thursday, September 12, you may jeopardize your eligibility to attend future Shea events.
Agenda
7:30 – 8:50 am: Registration/Breakfast
8:50 – 9:00 am: Introduction
9:00 – 9:30 am: Jason D. Merker, MD, PhD, UNC-Chapel Hill: How to Choose a Good Biomarker Panel
9:35 – 10:20 am: Shetal A. Patel, MD, PhD, UNC-Chapel Hill: Beyond EGFR, ALK, and ROS1: Actionable Genomic Alterations in 2024
10:25 – 10:55 am: Mark A. Socinski, MD, AdventHealth Medical Group, Florida: EGFR Mutations 20 years later: Current Frontline Options and Novel Subsequent Therapies
11:00 – 11:30 am: Discussion #1 (Q&A Molecular)
11:30 am – 12:15 pm: Lunch
12:15 – 1:00 pm: Julie R. Brahmer, MD, Johns Hopkins University: Dual Immunotherapy: When to Use It, When Not To
1:00 – 1:30 pm: Jared M. Weiss, MD, UNC-Chapel Hill: Targeted Immunotherapy for Solid Tumors—Closer Than You Think
1:30 – 2:00 pm: Discussion #2 (Q&A Immunotherapy)
2:00 – 2:30 pm: Break
2:30 – 3:00 pm: Siddharth H. Sheth, DO, UNC-Chapel Hill: Thyroid Cancer in 2024: Management Updates and Controversies in Clinical Practice
3:05 – 3:35 pm: Colette J. Shen, MD, PhD, UNC-Chapel Hill: Optimizing Radiation Therapy for Head and Neck Cancer: Novel Radiosensitizers and Radioprotectants Coming to Clinic
3:40 – 4:10 pm: Wendell G. Yarbrough, MD, UNC-Chapel Hill: HPV+ Head and Neck Cancer: Advances to Change Clinical Care
4:15 – 5:00 pm: Stephen V. Liu, MD, Georgetown University: Small Cells, Big Hope: Advances in SCLC
5:00 – 5:30 pm: Discussion #3 (Q&A Small Cell & Head/Neck)
5:30 pm: Closing remarks